摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[(2-Methoxyphenyl)methyl]imidazole | 102993-62-4

中文名称
——
中文别名
——
英文名称
1-[(2-Methoxyphenyl)methyl]imidazole
英文别名
——
1-[(2-Methoxyphenyl)methyl]imidazole化学式
CAS
102993-62-4
化学式
C11H12N2O
mdl
MFCD16302734
分子量
188.229
InChiKey
AGFSJIMXDCDFHW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.181
  • 拓扑面积:
    27
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1-[(2-Methoxyphenyl)methyl]imidazole正丁基锂 作用下, 以 四氢呋喃 为溶剂, 反应 3.75h, 以29%的产率得到2-iodo-1-(2-methoxybenzyl)-1H-imidazole
    参考文献:
    名称:
    Palladium-Catalyzed Intramolecular Arylation of N-Benzyl-2-iodoimidazoles: A Facile and Rapid Access to 5H-Imidazo[2,1-a]isoindoles
    摘要:
    首次报道了一种钯催化下的咪唑环C-2位点参与的分子内芳基化反应。应用此反应,可以一步从N-苄基-2-碘咪唑合成5H-咪唑并[2,1-a]异吲哚。微波辐照加速了反应速率,使得多种咪唑并[2,1-a]异吲哚类似物的合成成为可能。
    DOI:
    10.1055/s-2007-965896
  • 作为产物:
    描述:
    咪唑2-甲氧基氯化苄 在 sodium hydride 作用下, 以 乙二醇二甲醚 为溶剂, 反应 4.75h, 生成 1-[(2-Methoxyphenyl)methyl]imidazole
    参考文献:
    名称:
    Palladium-Catalyzed Intramolecular Arylation of N-Benzyl-2-iodoimidazoles: A Facile and Rapid Access to 5H-Imidazo[2,1-a]isoindoles
    摘要:
    首次报道了一种钯催化下的咪唑环C-2位点参与的分子内芳基化反应。应用此反应,可以一步从N-苄基-2-碘咪唑合成5H-咪唑并[2,1-a]异吲哚。微波辐照加速了反应速率,使得多种咪唑并[2,1-a]异吲哚类似物的合成成为可能。
    DOI:
    10.1055/s-2007-965896
点击查看最新优质反应信息

文献信息

  • BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
    申请人:Arvinas Operations, Inc.
    公开号:US20190300521A1
    公开(公告)日:2019-10-03
    The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand that binds to the Von Hippel-Lindau E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为SMARCA2或BRM(靶蛋白)的调节剂具有实用性。具体而言,本公开涉及包含一端结合Von Hippel-Lindau E3泛素连接酶的配体,另一端结合靶蛋白的双功能化合物,使得靶蛋白与泛素连接酶靠近以实现靶蛋白的降解(和抑制)。本公开展示了与靶蛋白降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由靶蛋白聚集或积累导致的疾病或紊乱。
  • [EN] ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE<br/>[FR] MODULATEURS DE PROTÉOLYSE À BASE D'ALANINE ET PROCÉDÉS D'UTILISATION ASSOCIÉS
    申请人:ARVINAS INC
    公开号:WO2017011590A1
    公开(公告)日:2017-01-19
    The description relates to inhibitors of Apoptosis Proteins (TAPs) binding compounds, including Afunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the IAP E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.
    描述涉及抑制凋亡蛋白(TAPs)结合化合物,包括包含相同的A功能化合物,这些化合物作为靶向泛素化的调节剂发挥作用,特别是根据本发明的双功能化合物抑制各种多肽和其他蛋白质的化合物。具体而言,描述提供了一端含有结合到IAP E3泛素连接酶的配体,另一端含有结合到靶蛋白的基团的化合物,使得靶蛋白靠近泛素连接酶以促使该蛋白的降解(和抑制)。可以合成化合物,表现出与几乎任何类型的靶向多肽的降解/抑制一致的广泛药理活性。
  • TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE
    申请人:Arvinas, Inc.
    公开号:US20180125821A1
    公开(公告)日:2018-05-10
    The present disclosure relates to bifunctional compounds, which find utility as modulators of tau protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tau protein, such that tau protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tau. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tau protein. Diseases or disorders that result from aggregation or accumulation of tau protein are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为tau蛋白的调节剂具有实用性。具体而言,本公开涉及含有一端结合到E3泛素连接酶的VHL或cereblon配体,另一端结合到tau蛋白的双功能化合物,使得tau蛋白与泛素连接酶靠近,以实现tau蛋白的降解(和抑制)。本公开展示了与tau蛋白降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由tau蛋白聚集或积累导致的疾病或紊乱。
  • [EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR LA DÉGRADATION CIBLÉE DE PROTÉINES CONTENANT UN BROMODOMAINE
    申请人:ARVINAS INC
    公开号:WO2017030814A1
    公开(公告)日:2017-02-23
    The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.
    本发明涉及双功能化合物,其作为靶向泛素化的调节剂具有实用性,特别是根据本发明抑制各种多肽和其他蛋白质的化合物。具体而言,本发明涉及一端含有结合泛素连接酶的VHL配体,另一端含有结合靶蛋白的基团的化合物,使得靶蛋白靠近泛素连接酶以促使该蛋白的降解(和抑制)。根据本发明的化合物表现出与靶向多肽的降解/抑制一致的广泛的药理活性。
  • COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 POLYPEPTIDES
    申请人:Arvinas, Inc.
    公开号:US20190151295A1
    公开(公告)日:2019-05-23
    The present disclosure relates to bifunctional compounds, which find utility as modulators of Interleukin-1 Receptor-Associated Kinase 4 (IRAK-4); the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hppel-Lindau, cereblon, ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为白细胞介素-1受体相关激酶4(IRAK-4;目标蛋白)的调节剂具有实用性。具体而言,本公开涉及包含一端结合E3泛素连接酶的Von Hppel-Lindau、cereblon配体的双功能化合物,另一端结合目标蛋白的部分,使得目标蛋白靠近泛素连接酶以实现目标蛋白的降解(和抑制)。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
查看更多